FDA Declines to Approve New Melanoma Therapy

In a complete response letter, the FDA indicates the drug trial is not an adequate, well-controlled clinical investigation, among other issues.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-declines-approve-new-melanoma-therapy-2025a1000jki?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension